CSE Symbol: CNVC
VANCOUVER, March 29, 2019 /CNW/ – Canna-V-Cell Sciences Inc. (The “Company”) (CSE: CNVC), CannaVcell is announcing today that as part of its program of applying the biofarming technology to Cannabis, it has achieved the important stage of being able to multiply cannabis cell tissues on solid media. Since the beginning of the program, the R&D team has been able to screen multiple cannabis plants and was able to combine the technology it developed over the last 10 years with the accumulated know-how to grow plant cells (in a form of a callus) in different colors: green, white and amber.
“The different callus colours are important indicators for the next stage of the cannabis cells development using the biofarming unique technology” said Dr. Yochi Hagay the CTO of CannaVcell while adding “we are excited about reaching this phase slightly ahead of schedule, demonstrating the team capabilities and instilling further confidence in the success of the program”.
Dr. Zaki Rakib, CEO added “I am delighted with the progress made so far. Every milestone reached brings closer the revolution to the Cannabis industry. Biofarming Cannabis allows the production of the active ingredients without growing the plant itself while keeping the entourage effect in tact. It does so with composition consistency, less cost, environmental friendliness and no toxic fungi”.
About Canna-V-Cell Sciences Inc.
Based in Vancouver BC, Canna-V-Cell Sciences Inc. (CNVC) is the exclusive Cannabis worldwide licensee of the proprietary and patent protected BioHarvest technology. It is the first and only industrial large scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. By adopting this technology and building adequate cells production capacity, Canna-V-Cell’s objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use.
Canna-V-Cell Sciences Inc.
Dr. Zaki Rakib
CEO
Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things, risks and uncertainties relating to the fact that the Company would require additional funds in order to construct a commercial biochamber facility and risks related to the adaption of the BioHarvest technology to cannabis. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release
SOURCE Canna-V-Cell Sciences Inc.
